Fundies. English
Segment disclosures
Company overviewSONOMA PHARMACEUTICALS, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
7 dimension combinations 119 retained observations 26 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Product · Animal Care
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=SNOA:AnimalCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 578000 | USD | 20230810 | Open filing evidence |
| 2022-04-01 – 2023-03-31 | 2500000 | USD | 20230621 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 434000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-12-31 | 1957000 | USD | 20230214 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 737000 | USD | 20221114 | Open filing evidence |
| 2022-04-01 – 2022-09-30 | 1523000 | USD | 20221114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 787000 | USD | 20230810 | Open filing evidence |
| 2021-04-01 – 2022-03-31 | 3169000 | USD | 20230621 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 818000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-12-31 | 2755000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1005000 | USD | 20221114 | Open filing evidence |
| 2021-04-01 – 2021-09-30 | 1937000 | USD | 20221114 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 812000 | USD | 20220811 | Open filing evidence |
| 2020-04-01 – 2021-03-31 | 3200000 | USD | 20220713 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 1357000 | USD | 20220211 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 2745000 | USD | 20220211 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 951000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 1388000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 377000 | USD | 20210816 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 2091000 | USD | 20210714 | Open filing evidence |
Product · Human Care
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=SNOA:HumanCareMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 2750000 | USD | 20230810 | Open filing evidence |
| 2022-04-01 – 2023-03-31 | 9426000 | USD | 20230621 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 2435000 | USD | 20230214 | Open filing evidence |
| 2022-04-01 – 2022-12-31 | 7050000 | USD | 20230214 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2447000 | USD | 20221114 | Open filing evidence |
| 2022-04-01 – 2022-09-30 | 4615000 | USD | 20221114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2168000 | USD | 20230810 | Open filing evidence |
| 2021-04-01 – 2022-03-31 | 9010000 | USD | 20230621 | Open filing evidence |
| 2021-10-01 – 2021-12-31 | 2015000 | USD | 20230214 | Open filing evidence |
| 2021-04-01 – 2021-12-31 | 7201000 | USD | 20230214 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 2591000 | USD | 20221114 | Open filing evidence |
| 2021-04-01 – 2021-09-30 | 5186000 | USD | 20221114 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 2715000 | USD | 20220811 | Open filing evidence |
| 2020-04-01 – 2021-03-31 | 15317000 | USD | 20220713 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 3534000 | USD | 20220211 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 13628000 | USD | 20220211 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 4776000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 10094000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5377000 | USD | 20210816 | Open filing evidence |
| 2019-04-01 – 2020-03-31 | 15686000 | USD | 20210714 | Open filing evidence |
Product · Service And Royalty
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=SNOA:ServiceAndRoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-10-01 – 2021-12-31 | 69000 | USD | 20220211 | Open filing evidence |
| 2021-04-01 – 2021-12-31 | 374000 | USD | 20220211 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 148000 | USD | 20211115 | Open filing evidence |
| 2021-04-01 – 2021-09-30 | 305000 | USD | 20211115 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 157000 | USD | 20210816 | Open filing evidence |
| 2020-10-01 – 2020-12-31 | 45000 | USD | 20220211 | Open filing evidence |
| 2020-04-01 – 2020-12-31 | 99000 | USD | 20220211 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 42000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-09-30 | 54000 | USD | 20211115 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 13000 | USD | 20210816 | Open filing evidence |
Service · Service And Royalty
Product Or Service · Statement Business Segments
Source dimensions
srt:ProductOrServiceAxis=us-gaap:ServiceMember;us-gaap:StatementBusinessSegmentsAxis=SNOA:ServiceAndRoyaltyMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-04-01 – 2025-03-31 | 556000 | USD | 20250617 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 136000 | USD | 20250205 | Open filing evidence |
| 2024-04-01 – 2024-12-31 | 472000 | USD | 20250205 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 220000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-09-30 | 336000 | USD | 20241107 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 116000 | USD | 20240808 | Open filing evidence |
| 2023-04-01 – 2024-03-31 | 422000 | USD | 20250617 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 56000 | USD | 20250205 | Open filing evidence |
| 2023-04-01 – 2023-12-31 | 322000 | USD | 20250205 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 167000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-09-30 | 266000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 99000 | USD | 20240808 | Open filing evidence |
| 2022-04-01 – 2023-03-31 | 1346000 | USD | 20240617 | Open filing evidence |
Animal Care · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=SNOA:AnimalCareMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 439000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2026-03-31 | 1848000 | USD | 20260616 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 486000 | USD | 20260210 | Open filing evidence |
| 2025-04-01 – 2025-12-31 | 1434000 | USD | 20260210 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 488000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-09-30 | 948000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 460000 | USD | 20260806 | Open filing evidence |
| 2024-04-01 – 2025-03-31 | 1653000 | USD | 20260616 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 376000 | USD | 20260210 | Open filing evidence |
| 2024-04-01 – 2024-12-31 | 1176000 | USD | 20260210 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 402000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-09-30 | 801000 | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 399000 | USD | 20250807 | Open filing evidence |
| 2023-04-01 – 2024-03-31 | 2203000 | USD | 20250617 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 621000 | USD | 20250205 | Open filing evidence |
| 2023-04-01 – 2023-12-31 | 1688000 | USD | 20250205 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 489000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-09-30 | 1067000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 578000 | USD | 20240808 | Open filing evidence |
| 2022-04-01 – 2023-03-31 | 2500000 | USD | 20240617 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 434000 | USD | 20240208 | Open filing evidence |
| 2022-04-01 – 2022-12-31 | 1957000 | USD | 20240208 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 737000 | USD | 20231113 | Open filing evidence |
| 2022-04-01 – 2022-09-30 | 1523000 | USD | 20231113 | Open filing evidence |
Human Care · Product
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=SNOA:HumanCareMember;srt:ProductOrServiceAxis=us-gaap:ProductMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 5967000 | USD | 20260806 | Open filing evidence |
| 2025-04-01 – 2026-03-31 | 17681000 | USD | 20260616 | Open filing evidence |
| 2025-10-01 – 2025-12-31 | 3863000 | USD | 20260210 | Open filing evidence |
| 2025-04-01 – 2025-12-31 | 12534000 | USD | 20260210 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5116000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-09-30 | 8671000 | USD | 20251104 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 3555000 | USD | 20260806 | Open filing evidence |
| 2024-04-01 – 2025-03-31 | 12635000 Restated | USD | 20260616 | Open filing evidence |
| 2024-10-01 – 2024-12-31 | 3188000 Restated | USD | 20260210 | Open filing evidence |
| 2024-04-01 – 2024-12-31 | 9358000 Restated | USD | 20260210 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 3177000 Restated | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-09-30 | 6169000 Restated | USD | 20251104 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 2992000 Restated | USD | 20250807 | Open filing evidence |
| 2023-04-01 – 2024-03-31 | 10110000 | USD | 20250617 | Open filing evidence |
| 2023-10-01 – 2023-12-31 | 2461000 | USD | 20250205 | Open filing evidence |
| 2023-04-01 – 2023-12-31 | 7286000 | USD | 20250205 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 2075000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-09-30 | 4825000 | USD | 20241107 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 2750000 | USD | 20240808 | Open filing evidence |
| 2022-04-01 – 2023-03-31 | 9426000 | USD | 20240617 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 2435000 | USD | 20240208 | Open filing evidence |
| 2022-04-01 – 2022-12-31 | 7050000 | USD | 20240208 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2447000 | USD | 20231113 | Open filing evidence |
| 2022-04-01 – 2022-09-30 | 4615000 | USD | 20231113 | Open filing evidence |
Service And Royalty · Service
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=SNOA:ServiceAndRoyaltyMember;srt:ProductOrServiceAxis=us-gaap:ServiceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-10-01 – 2023-12-31 | 56000 | USD | 20240208 | Open filing evidence |
| 2023-04-01 – 2023-12-31 | 322000 | USD | 20240208 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 167000 | USD | 20231113 | Open filing evidence |
| 2023-04-01 – 2023-09-30 | 266000 | USD | 20231113 | Open filing evidence |
| 2022-10-01 – 2022-12-31 | 75000 | USD | 20240208 | Open filing evidence |
| 2022-04-01 – 2022-12-31 | 1251000 | USD | 20240208 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 147000 | USD | 20231113 | Open filing evidence |
| 2022-04-01 – 2022-09-30 | 1176000 | USD | 20231113 | Open filing evidence |